Inventor · disambiguated record
Paul H. Bessette
Also filed as: BESSETTE PAUL · BESSETTE PAUL H · BESSETTE PAUL HENRY
28 granted patents·11 pending applications·1,063 citations·filing 1997–2024
98Inventor score
Files withCYTOMX THERAPEUTICS INC15UNIV CALIFORNIA8ASHER BIOTHERAPEUTICS INC3PFIZER3STAGLIANO NANCY E3
Top patents by PatentIndex Score
39 records- 0198US10875913B2Methods of treatment using activatable anti-EGFR antibodiesCYTOMX THERAPEUTICS INC·Filed 2018·Granted Dec 29, 2020·21 cites·40 claims
- 0298US10118961B2Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWVCYTOMX THERAPEUTICS INC·Filed 2016·Granted Nov 6, 2018·34 cites·13 claims
- 0398US10059762B2Anti-EGFR activatable antibodiesCYTOMX THERAPEUTICS INC·Filed 2016·Granted Aug 28, 2018·42 cites·41 claims
- 0498US9644016B2Soluble notch receptor proproteins and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2015·Granted May 9, 2017·34 cites·28 claims
- 0598US8513390B2Modified antibody compositions, methods of making and using thereofSTAGLIANO NANCY E·Filed 2012·Granted Aug 20, 2013·111 cites·137 claims
- 0697US9127053B2Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2013·Granted Sep 8, 2015·39 cites·33 claims
- 0797US8563269B2Modified antibody compositions, methods of making and using thereofSTAGLIANO NANCY E·Filed 2011·Granted Oct 22, 2013·119 cites·38 claims
- 0897US8399219B2Protease activatable interferon alpha proproteinSTAGLIANO NANCY E·Filed 2010·Granted Mar 19, 2013·46 cites·17 claims
- 0996US9453078B2Modified antibody compositions, methods of making and using thereofCYTOMX THERAPETUICS INC·Filed 2013·Granted Sep 27, 2016·64 cites·28 claims
- 1096US8993266B2Proproteins activatable interferon alphaCYTOMX THERAPEUTICS INC·Filed 2012·Granted Mar 31, 2015·28 cites·14 claims
- 1196US7612019B2Polypeptide display libraries and methods of making and using thereofUNIV CALIFORNIA·Filed 2006·Granted Nov 3, 2009·23 cites·18 claims
- 1296US7256038B2Polypeptide display libraries and methods of making and using thereofUNIV CALIFORNIA·Filed 2004·Granted Aug 14, 2007·45 cites·21 claims
- 1395US10513549B2Cleavage-activatable interferon-alpha proproteinCYTOMX THERAPEUTICS INC·Filed 2017·Granted Dec 24, 2019·14 cites·11 claims
- 1495US10301380B2Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·17 cites·29 claims
- 1595US8361933B2Polypeptide display libraries and methods of making and using thereofUNIV CALIFORNIA·Filed 2009·Granted Jan 29, 2013·20 cites·21 claims
- 1695US6083715AMethods for producing heterologous disulfide bond-containing polypeptides in bacterial cellsUNIV TEXAS·Filed 1997·Granted Jul 4, 2000·295 cites·46 claims
- 1794US10041063B2Polypeptide display libraries and methods of making and using thereofUNIV CALIFORNIA·Filed 2015·Granted Aug 7, 2018·5 cites·17 claims
- 1894US9134309B2Polypeptide display libraries and methods of making and using thereofUNIV CALIFORNIA·Filed 2012·Granted Sep 15, 2015·9 cites·32 claims
- 1993US9688748B2Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2015·Granted Jun 27, 2017·11 cites·39 claims
- 2092US6872563B1Compositions and methods for production of disulfide bond containing proteins in host cellsHARVARD COLLEGE·Filed 2000·Granted Mar 29, 2005·61 cites·30 claims
- 2190US10138298B2Anti-IL-2 antibodies and compositions and uses thereofPFIZER·Filed 2016·Granted Nov 27, 2018·14 cites·24 claims
- 2290US2024228603A1Modified antibody compositions, methods of making and using thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2389US11078479B2Polypeptide display libraries and methods of making and using thereofUNIV CALIFORNIA·Filed 2019·Granted Aug 3, 2021·1 cites·18 claims
- 2485US12024559B2Fusions with CD8 antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2021·Granted Jul 2, 2024·2 cites·95 claims
- 2585US2023183308A1Proproteins and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2681US11459385B2Anti-IL-2 antibodies and compositions and uses thereofPFIZER·Filed 2020·Granted Oct 4, 2022·1 cites·15 claims
- 2781US2023035290A1Proproteins and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2880US7410788B2Compositions and methods for production of disulfide bond containing proteins in host cellsHARVARD COLLEGE·Filed 2005·Granted Aug 12, 2008·5 cites·39 claims
- 2979US2022119802A1Polypeptide display libraries and methods of making and using thereofUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3078US10738113B2Anti-IL-2 antibodies and compositions and uses thereofPFIZER·Filed 2018·Granted Aug 11, 2020·2 cites·6 claims
- 3176US2021284721A1Modified antibody compositions, methods of making and using thereofCYTOMX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3275US10544410B2Polypeptide display libraries and methods of making and using thereofUNIV CALIFORNIA·Filed 2018·Granted Jan 28, 2020·0 cites·17 claims
- 3374US2020308243A1Proproteins and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3466US2024417470A1Fusions with cd8 antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3563US2019367589A1Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3662US2013309230A1Modified Antibody Compositions, Methods of Making and Using ThereofCYTOMX THERAPETUICS INC·Filed 2013·Application pending·0 cites
- 3756US10526560B1Protective lubricant formulation and method of useCLARKE BENJAMIN·Filed 2018·Granted Jan 7, 2020·0 cites·4 claims
- 3856US2010189651A1Modified antibody compositions, methods of making and using thereofCYTOMX THERAPEUTICS LLC·Filed 2010·Application pending·0 cites
- 3952US2024043490A1Targeted cytokine construct for engineered cell therapyASHER BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul H. Bessette files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →